Matching slides 110,471
Current window 86,161-86,190
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

86,161-86,190 of 110,471

filter-aware
03
Advantage Solutions | Investor Presentation Deck | 25 slidesAdvantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
08
The slide uses a donut chart to visualize market share and lists service capabilities across four key pillars.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · Market Size1 hit
16
The slide uses a four-column layout to categorize strategic financial priorities.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
25
This is the final slide in a series of non-GAAP reconciliation disclosures.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
03
The slide uses a visual process flow to explain the competitive inhibition mechanism.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
04
The slide uses a timeline-based process flow to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
08
The chart includes error bars and a table of participant counts at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Before-After Comparison1 hit
15
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
08
The slide uses a timeline framework to establish credibility and future-looking innovation.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
26
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
27
The table compares adverse event (AE) frequencies, treatment-related AEs (TRAEs), and dose modifications.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
29
The slide summarizes the primary outcomes of the SERENA-2 trial, confirming PFS benefits and safety, and mentions ongoing Phase III trials (SERENA-4 and SERENA-6).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
31
Includes Kaplan-Meier survival curve and key efficacy metrics.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
03
The slide uses a split-layout with a blue sidebar for corporate identity and a large background image of a deck.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
06
The slide combines financial performance charts with a company overview and key operational metrics.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
07
Includes a callout regarding architect popularity and a note on the replacement cycle of existing decks.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
24
The slide uses bar charts to show quality ratings and a bulleted list for social proof/awards.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
25
Uses a Good-Better-Best-Premium framework to organize product offerings.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
02
Azerion | Investor Day Presentation Deck | 48 slidesAzerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
24
The slide uses a forest plot to visualize the odds ratio (0.60) with a 95% confidence interval (0.27, 1.29) crossing the null value of 1.0.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
25
Uses a visual comparison to explain the biological mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a bulleted list to frame the clinical trial narrative from failure to a focused subgroup opportunity.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
44
The slide uses a tree metaphor for the study name 'CYPRESS'.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
02
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a process-style arrow diagram to present three core financial metrics.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
The slide highlights a strong balance sheet with $274M cash and $274M debt, plus an undrawn $100M credit facility.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
14
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Action1 hit